Loading organizations...
Brookline Investment Group is an investment firm that acquires and operates income-producing real estate across the United States. The company strategically targets core, value-add, and opportunistic investments in multi-family and commercial properties, building a substantial portfolio through focused acquisition and active management.
Michael Narlinger founded Brookline Investment Group in mid-2013, leveraging his entrepreneurial background from successfully growing Valutech Outsourcing, LLC. His insight was to apply a family office approach to real estate investment, enabling swift acquisitions with discretionary capital. Narlinger, with a finance degree from Villanova University, brought strong financial acumen to the venture.
Brookline Investment Group serves accredited investors and partners seeking exposure to real estate assets, focusing on opportunities for value appreciation and income generation. Its long-term vision involves continued strategic expansion of its income property portfolio, emphasizing meticulous underwriting and operational management to optimize asset performance and deliver consistent returns.
Brookline Investments has 2 tracked investments across 1 company. The latest tracked deal is $27.0M Series B in TRACON Pharmaceuticals in September 2014.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2014 | TRACON Pharmaceuticals | $27.0M Series B | — | NEW Enterprise Associates, Arcus Ventures, BHP Ventures, Bruce D. Steel, Jafco Ventures, Nextech Invest |
| Apr 22, 2011 | TRACON Pharmaceuticals | $14.0M Other Equity | Hironori Hozoji, Myoung OK Kwon, Prof. PHD | Arcus Ventures, BHP Ventures |